首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Arthritis & rheumatology

缩写:ARTHRITIS RHEUMATOL

ISSN:2326-5191

e-ISSN:2326-5205

IF/分区:9.9/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引4617条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Yahong Wu,Yanning Xu,Paul C Okoro et al. Yahong Wu et al.
Objective: Chondrocalcinosis, characterized by calcium crystal deposition within articular cartilage, affects 5% to 15% of the general population and has recently been identified as an osteoarthritis risk factor. However,...
Mikel Gurrea-Rubio,Laura A Cooney,Kohei Maeda et al. Mikel Gurrea-Rubio et al.
Objective: Systemic sclerosis (SSc) is characterized by immune dysregulation and fibrosis. We investigated whether abatacept modulates CD319/SLAMF7-expressing cytotoxic T cells implicated in diffuse cutaneous SSc. ...
Liangyu Chen,Junfeng Wu,Tao Zhou et al. Liangyu Chen et al.
Objective: Fibroblast-like synoviocytes (FLS) in rheumatoid arthritis (RA) synovium acquire a unique aggressive phenotype and produce cytokines that perpetuate inflammation and proteases that contribute to cartilage destr...
Karine Tankovic,Pascal Claudepierre,Tat Thang Vo et al. Karine Tankovic et al.
Objective: To assess the association between duration of targeted therapy exposure and cancer risk in patients with spondyloarthritis (SpA), including those with psoriatic arthritis, axial SpA, and other subtypes. ...
Huizhong Long,Elio Carmona,Mikhail G Dozmorov et al. Huizhong Long et al.
Objective: Systemic lupus erythematosus (SLE) is characterized by type I interferon (IFN) signaling and adaptive immune dysregulation. We previously identified hypomethylation of HLA-DRB1 and STAT1 in SLE CD8+ T cells, en...
Arjun Mahajan,Maureen Whittelsey,Ruth Ann Vleugels et al. Arjun Mahajan et al.
Objective: Current guidelines recommend anifrolumab and belimumab as comparably viable immunosuppressive therapies for active systemic lupus erythematosus (SLE), yet comparative evidence remains limited. Patients with SLE...
Joel A Block Joel A Block
Despite revolutionary advances in therapeutics for many of the inflammatory rheumatic diseases, osteoarthritis (OA) has not been one of the diseases for which therapy has advanced dramatically, and OA pain frequently remains incompletely co...
Chenglong Fang,Xiaoxi Yang,Xiaochuan Sun et al. Chenglong Fang et al.
Objective: Although Takayasu's arteritis (TAK) is not a prototypical autoantibody-mediated disease, accumulating evidence suggests that B cells are involved. This study aimed to investigate the pathway of B-cell activatio...
Sonali J Bracken,Jeremy M Weber,Megan L Neely et al. Sonali J Bracken et al.
Objective: We evaluated baseline characteristics, treatment patterns, and outcomes in patients with systemic autoimmune rheumatic disease-associated progressive pulmonary fibrosis (SARD-PPF) and evaluated whether outcomes...